CLNN · Clene Inc.

NasdaqHealthcareBiotechnology

Clene Inc Is A Clinical-Stage Pharmaceutical Company Pioneering The Discovery, Development, And Commercialization Of Novel Clean-Surfaced Nanotechnology (Csn) Therapeutics. It Is Focused On The Development Of Therapeutics For Neurodegenerative Diseases. It Developed An Electro-Crystal-Chemistry Drug Development Platform That Enables The Production Of Concentrated, Stable, Clean-Surfaced Nanocrystal Suspensions. It Operates In One Segment The Development And Commercialization Of Dietary Supplements (Supplements). Products Includes Cnm-Au8, Cnm-Zna, Cnm-Agzn17, Rmetx, Khc46.

HealthcareNasdaqUSLow Float

$9.78

+63.0% latest move

Price & move as of the most recent catalyst (May 4) — not a live quote.

FLOAT

8.3M

FREE FLOAT %

64%

SHARES O/S

13.0M

MARKET CAP

$52.3M

EXCHANGE

Nasdaq

COUNTRY

CLNN Catalyst History

Regulatory and ClinicalMay 4, 2026 · 8:03am ET

CLNNClene Inc.

FDA Approves Clene Inc.'s Data Submission for ALS Treatment Pathway

Regulatory milestone achieved for Clene's proposed drug application.

Be early on the next CLNN spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →